Lysophosphatidic acid enhances interleukin-13 gene expression and promoter activity in T cells

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 290, Issue 1, 2006, Pages

  Rubenfeld, Joshua ^a   Guo, Jia ^a   Sookrung, Nitat ^a   Chen, Rongbing ^a   Chaicumpa, Wanpen ^b   Casolaro, Vincenzo ^a   Zhao, Yutong ^a   Natarajan, Viswanathan ^a   Georas, Steve ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b THAMMASAT UNIVERSITY   (Thailand)

^c JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

Inflammation; Lysophospholipids; T lymphocytes; Transcription factors; Transcriptional regulation

Indexed keywords

CALCIMYCIN; CALCIUM; CD3 ANTIBODY; CYCLIC AMP; INTERLEUKIN 13; LUCIFERASE; LYSOPHOSPHATIDIC ACID; MESSENGER RNA; MONOCLONAL ANTIBODY CD28; PROTEIN KINASE C; T LYMPHOCYTE RECEPTOR; IONOPHORE; ISOPROTEIN; LYSOPHOSPHOLIPID;

ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; ELECTROPORATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; CD4+ T LYMPHOCYTE; DRUG EFFECT; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PHYSIOLOGY;

CALCIMYCIN; CD4-POSITIVE T-LYMPHOCYTES; GENE EXPRESSION; HUMANS; INTERLEUKIN-13; IONOPHORES; JURKAT CELLS; LYSOPHOSPHOLIPIDS; PROMOTER REGIONS (GENETICS); PROTEIN ISOFORMS; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC;

EID: 33644802427     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00473.2004     Document Type: Article

References (53)

1. 2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J Immunol 146: 108-113, 1991.
2. Blackburn MR, Lee CG, Young HW, Zhu Z, Chunn JL, Kang MJ, Banerjee SK, and Elias JA. Adenosine mediates IL-13-induced inflammation and remodeling in the lung and interacts in an IL-13-adenosine amplification pathway. J Clin Invest 112: 332-344, 2003.
3. Brogdon JL, Leitenberg D, and Bottomly K. The potency of TCR signaling differentially regulates NFATc/p activity and early IL-4 transcription in naive CD4+ T cells. J Immunol 168: 3825-3832, 2002.
4. Casolaro V, Georas S, Song Z, Zubkoff I, Abdulkadir S, Thanos D, and Ono S. Inhibition of NF-AT-dependent transcription by NF-κB: implications for differential cytokine gene expression. Proc Natl Acad Sci USA 92: 11623-11627, 1995.
5. Chen CH, Zhang DH, LaPorte JM, and Ray A. Cyclic AMP activates p38 mitogen-activated protein kinase in Th2 cells: phosphorylation of GATA-3 and stimulation of Th2 cytokine gene expression. J Immunol 165: 5597-5605, 2000.
6. Chu P, Pardo J, Zhao H, Li CC, Pali E, Shen MM, Qu K, Yu SX, Huang BC, Yu P, Masuda ES, Molineaux SM, Kolbinger F, Aversa G, De Vries J, Payan DG, and Liao XC. Systematic identification of regulatory proteins critical for T-cell activation. J Biol 2: 21, 2003.
7. Chun J, Goetzl EJ, Hla T, Igarashi Y, Lynch KR, Moolenaar W, Pyne S, and Tigyi G. International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature. Pharmacol Rev 54: 265-269, 2002.
8. Colgan J, Asmal M, Neagu M, Yu B, Schneidkraut J, Lee Y, Sokolskaja E, Andreotti A, and Luban J. Cyclophilin A regulates TCR signal strength in CD4+ T cells via a proline-directed conformational switch in Itk. Immunity 21: 189-201, 2004.
9. De AK, Kodys K, and Miller-Graziano C. Maximal T cell IL-13 production requires monocyte or monokine participation. Cytokine 10: 911-919, 1998.
10. Dolganov G, Bort S, Lovett M, Burr J, Schubert L, Short D, McGurn M, Gibson C, and Lewis DB. Coexpression of the interleukin-13 and interleukin-4 genes correlates with their physical linkage in the cytokine gene cluster on human chromosome 5q23-31. Blood 87: 3316-3326, 1996.
11. Dumont FJ, Staruch MJ, Fischer P, DaSilva C, and Camacho R. Inhibition of T cell activation by pharmacologic disruption of the MEK1/ERK MAP kinase or calcineurin signaling pathways results in differential modulation of cytokine production. J Immunol 160: 2579-2589, 1998.
12. Ediger TL, Danforth BL, and Toews ML. Lysophosphatidic acid upregulates the epidermal growth factor receptor in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 282: L91-L98, 2002.
13. Elliott KA, Osna NA, Scofield MA, and Khan MM. Regulation of IL-13 production by histamine in cloned murine T helper type 2 cells. Int Immunopharmacol 1: 1923-1937, 2001.
14. 2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell 80: 919-927, 1995.
15. Fukushima N and Chun J. The LPA receptors. Prostaglandins 64: 21-32, 2001.
16. Gobeil F Jr, Bernier SG, Vazquez-Tello A, Brault S, Beauchamp MH, Quiniou C, Marrache AM, Checchin D, Sennlaub F, Hou X, Nader M, Bkaily G, Ribeiro-da-Silva A, Goetzl EJ, and Chemtob S. Modulation of pro-inflammatory gene expression by nuclear lysophosphatidic acid receptor type-1. J Biol Chem 278: 38875-38883, 2003.
17. Goetzl EJ, Kong Y, and Mei B. Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax. J Immunol 162: 2049-2056, 1999.
18. Goetzl EJ, Kong Y, and Voice JK. Cutting edge: differential constitutive expression of functional receptors for lysophosphatidic acid by human blood lymphocytes. J Immunol 164: 4996-4999, 2000.
19. Goetzl EJ and Rosen H. Regulation of immunity by lysosphingolipids and their G protein-coupled receptors. J Clin Invest 114: 1531-1537, 2004.
20. Graeler MH and Goetzl EJ. Lysophospholipids and their G protein-coupled receptors in inflammation and immunity. Biochim Biophys Acta 1582: 168-174, 2002.
21. Grunig G, Warnock M, Wakil AE, Venkayya R, Brombacher F, Rennick DM, Sheppard D, Mohrs M, Donaldson DD, Locksley RM, and Corry DB. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282: 2261-2263, 1998.
22. Guo J, Casolaro V, Seto E, Yang WM, Chang C, Seminario MC, Keen J, and Georas SN. Yin-Yang 1 activates interleukin-4 gene expression in T cells. J Biol Chem 276: 48871-48878, 2001.
23. Hayes SM, Li L, and Love PE. TCR signal strength influences αβ/γδ lineage fate. Immunity 22: 583-593, 2005.
24. Huang MC, Graeler M, Shankar G, Spencer J, and Goetzl EJ. Lysophospholipid mediators of immunity and neoplasia. Biochim Biophys Acta 1582: 161-167, 2002.
25. Jorritsma PJ, Brogdon JL, and Bottomly K. Role of TCR-induced extracellular signal-regulated kinase activation in the regulation of early IL-4 expression in naive CD4+ T cells. J Immunol 170: 2427-2434, 2003.
26. Kishikawa H, Sun J, Choi A, Miaw SC, and Ho IC. The cell type-specific expression of the murine IL-13 gene is regulated by gata-3. J Immunol 167: 4414-4420, 2001.
27. Klein-Hessling S, Jha MK, Santner-Nanan B, Berberich-Siebelt F, Baumruker T, Schimpl A, and Serfling E. Protein kinase A regulates GATA-3-dependent activation of IL-5 gene expression in Th2 cells. J Immunol 170: 2956-2961, 2003.
28. Koning H, Neijens HJ, Baert MR, Oranje AP, and Savelkoul HF. T cell subsets and cytokines in allergic and non-allergic children. I. Analysis of IL-4, IFN-γ and IL-13 mRNA expression and protein production. Cytokine 9: 416-426, 1997.
29. Kuperman DA, Huang X, Koth LL, Chang GH, Dolganov GM, Zhu Z, Elias JA, Sheppard D, and Erle DJ. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat Med 8: 885-889, 2002.
30. Le LQ, Kabarowski JH, Weng Z, Satterthwaite AB, Harvill ET, Jensen ER, Miller JF, and Witte ON. Mice lacking the orphan G protein-coupled receptor G2A develop a late-onset autoimmune syndrome. Immunity 14: 561-571, 2001.
31. Matsukura S, Stellato C, Georas SN, Casolaro V, Plitt JR, Miura K, Kurosawa S, Schindler U, and Schleimer RP. Interleukin-13 upregulates eotaxin expression in airway epithelial cells by a stat6-dependent mechanism. Am J Respir Cell Mol Biol 24: 755-761, 2001.
32. McKenzie AN, Li X, Largaespada DA, Sato A, Kaneda A, Zurawski SM, Doyle EL, Milatovich A, Francke U, Copeland NG, Jenkins NA, and Zurawski G. Structural comparison and chromosomal localization of the human and mouse IL-13 genes. J Immunol 150: 5436-5444, 1993.
33. Meerschaert K, De Corte V, De Ville Y, Vandekerckhove J, and Gettemans J. Gelsolin and functionally similar actin-binding proteins are regulated by lysophosphatidic acid. EMBO J 17: 5923-5932, 1998.
34. Mills GB and Moolenaar WH. The emerging role of lysophosphatidic acid in cancer. Nat Rev Cancer 3: 582-591, 2003.
35. Moolenaar WH, Kranenburg O, Postma FR, and Zondag GC. Lysophosphatidic acid: G-protein signalling and cellular responses. Curr Opin Cell Biol 9: 168-173, 1997.
36. Neumann M, Grieshammer T, Chuvpilo S, Kneitz B, Lohoff M, Schimpl A, Franza BR Jr, and Serfling E. RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A. EMBO J 14: 1991-2004, 1995.
37. Noguchi K, Ishii S, and Shimizu T. Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family. J Biol Chem 278: 25600-25606, 2003.
38. Pahl A, Zhang M, Kuss H, Szelenyi I, and Brune K. Regulation of IL-13 synthesis in human lymphocytes: implications for asthma therapy. Br J Pharmacol 135: 1915-1926, 2002.
39. Palmetshofer A, Robson SC, and Nehls V. Lysophosphatidic acid activates nuclear factor κB and induces proinflammatory gene expression in endothelial cells. Thromb Haemost 82: 1532-1537, 1999.
40. Panther E, Idzko M, Corinti S, Ferrari D, Herouy Y, Mockenhaupt M, Dichmann S, Gebicke-Haerter P, Di Virgilio F, Girolomoni G, and Norgauer J. The influence of lysophosphatidic acid on the functions of human dendritic cells. J Immunol 169: 4129-4135, 2002.
41. Rao A, Luo C, and Hogan P. Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 15: 707-747, 1997.
42. Schade AE and Levine AD. Cutting edge: extracellular signal-regulated kinases 1/2 function as integrators of TCR signal strength. J Immunol 172: 5828-5832, 2004.
43. Shahrestanifar M, Fan X, and Manning DR. Lysophosphatidic acid activates NF-κB in fibroblasts. A requirement for multiple inputs. J Biol Chem 274: 3828-3833, 1999.
44. 2+ entry at plasma membrane in Jurkat human T-cells. Biochem J 319: 393-397, 1996.
45. 2 on helper T cell functions. Biochem Biophys Res Commun 316: 1009-1014, 2004.
46. Van der Pouw Kraan TC, Boeije LC, Troon JT, Rutschmann SK, Wijdenes J, and Aarden LA. Human IL-13 production is negatively influenced by CD3 engagement. Enhancement of IL-13 production by cyclosporin A. J Immunol 156: 1818-1823, 1996.
47. Van der Pouw-Kraan T, Van Veen A, Boeije LC, Van Tuyl S, de Groot E, Stapel SO, Bakker A, Verweij AL, Aarden LA, and Van der Zee JS. An IL-13 promoter polymorphism associated with increased risk of allergic asthma. Genes Immun 1: 61-65, 1999.
48. 2 in lysophosphatidate-induced transactivation of platelet-derived growth factor receptor-β in human bronchial epithelial cells. J Biol Chem 278: 39931-39940, 2003.
49. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 17: 255-281, 1999.
50. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, and Donaldson DD. Interleukin-13: central mediator of allergic asthma. Science 282: 2258-2261, 1998.
51. Zhao Y, Usatyuk PV, Cummings R, Saatian B, He D, Watkins T, Morris A, Spannhake EW, Brindley DN, and Natarajan V. Lipid phosphate phosphatase-1 regulates lysophosphatidic acid-induced calcium release, NF-κB activation and IL-8 secretion in human bronchial epithelial cells. Biochem J 385: 493-502, 2005.
52. Zheng Y, Kong Y, and Goetzl EJ. Lysophosphatidic acid receptor-selective effects on Jurkat T cell migration through a Matrigel model basement membrane. J Immunol 166: 2317-2322, 2001.
53. Zheng Y, Voice JK, Kong Y, and Goetzl EJ. Altered expression and functional profile of lysophosphatidic acid receptors in mitogen-activated human blood T lymphocytes. FASEB J 14: 2387-2389, 2000.